- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| CV SCIENCES Aktie jetzt für 0€ handeln | |||||
| 23.12.25 | CV Sciences, Inc. Positioned to Participate in the Medicare and Medicaid Pilot Program for CBD | 539 | ACCESS Newswire | SAN DIEGO, CA / ACCESS Newswire / December 22, 2025 / CV Sciences, Inc. (OTCQB:CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent consumer wellness company specializing in hemp... ► Artikel lesen | |
| 14.11.25 | CV Sciences outlines new non-cannabinoid product launches in 2026 while adapting to regulatory changes | 3 | Seeking Alpha | ||
| 13.11.25 | CV Sciences GAAP EPS of $0.00, revenue of $3.26M | 2 | Seeking Alpha | ||
| 13.11.25 | CV Sciences, Inc. - 10-Q, Quarterly Report | - | SEC Filings | ||
| 13.11.25 | CV Sciences, Inc. Reports Third Quarter 2025 Financial Results | 284 | ACCESS Newswire | SAN DIEGO, CA / ACCESS Newswire / November 13, 2025 / CV Sciences, Inc. (OTCQB:CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent consumer wellness company specializing in hemp... ► Artikel lesen | |
| 11.11.25 | CV Sciences, Inc. to Announce Third Quarter 2025 Results on November 13, 2025 | 355 | ACCESS Newswire | SAN DIEGO, CALIFORNIA / ACCESS Newswire / November 10, 2025 / CV Sciences, Inc. (OTCQB:CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent consumer wellness company specializing... ► Artikel lesen | |
| 10.10.25 | CV Sciences, Inc. - 8-K, Current Report | 3 | SEC Filings | ||
| 18.09.25 | CV Sciences, Inc. - 8-K, Current Report | 2 | SEC Filings | ||
| 27.08.25 | CV Sciences, Inc.: CV Sciences Launches Ignite: A Men's Performance Formula for Vitality, Recovery, Libido & Focus | 523 | ACCESS Newswire | Ignite delivers a powerful blend of proven botanicals along with our award-winning CBD, designed to help men stay strong, sharp, and ready-at work, in the gym, and beyond. SAN DIEGO, CALIFORNIA / ACCESS... ► Artikel lesen | |
| 13.08.25 | CV Sciences, Inc. Reports Second Quarter 2025 Financial Results | 341 | ACCESS Newswire | SAN DIEGO, CA / ACCESS Newswire / August 13, 2025 / CV Sciences, Inc. (OTCQB:CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent consumer wellness company specializing in hemp extracts... ► Artikel lesen | |
| 08.08.25 | CV Sciences, Inc. To Announce Second Quarter 2025 Results On August 13, 2025 | 590 | ACCESS Newswire | SAN DIEGO, CALIFORNIA / ACCESS Newswire / August 8, 2025 / CV Sciences, Inc. (OTCQB:CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent consumer wellness company specializing in... ► Artikel lesen | |
| 24.06.25 | CV Sciences, Inc. Applauds Governor Abbot's Veto of Senate Bill 3 | 431 | ACCESS Newswire | SAN DIEGO, CALIFORNIA / ACCESS Newswire / June 23, 2025 / CV Sciences, Inc. (OTCQB:CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent consumer wellness company specializing in hemp... ► Artikel lesen | |
| 14.05.25 | CV Sciences, Inc. Reports First Quarter 2025 Financial Results | 397 | ACCESS Newswire | SAN DIEGO, CA / ACCESS Newswire / May 14, 2025 / CV Sciences, Inc. (OTCQB:CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent consumer wellness company specializing in hemp extracts... ► Artikel lesen | |
| 10.05.25 | CV Sciences, Inc. to Announce First Quarter 2025 Results on May 14, 2025 | 461 | ACCESS Newswire | SAN DIEGO, CA / ACCESS Newswire / May 9, 2025 / CV Sciences, Inc. (OTCQB:CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent consumer wellness company specializing in hemp extracts... ► Artikel lesen | |
| 27.03.25 | CV Sciences, Inc. Reports Fiscal Year-End 2024 Financial Results | 546 | ACCESS Newswire | SAN DIEGO, CA / ACCESS Newswire / March 27, 2025 / CV Sciences, Inc. (OTCQB:CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent consumer wellness company specializing in hemp extracts... ► Artikel lesen | |
| 26.03.25 | CV Sciences, Inc.: CV Sciences Unveils Lunar Fox Food Co., an All-New Line of Plant-Based Foods | 1.037 | ACCESS Newswire | The innovative product line offers a unique choice of plant-based, 100% natural alternatives to the foods everyone loves. SAN DIEGO, CA / ACCESS Newswire / March 26, 2025 / CV Sciences, Inc. (OTCQB:CVSI)... ► Artikel lesen | |
| 20.03.25 | CV Sciences, Inc. To Announce Year End and Fourth Quarter 2024 Results On March 27, 2025 | 366 | ACCESS Newswire | SAN DIEGO, CALIFORNIA / ACCESS Newswire / March 20, 2025 / CV Sciences, Inc. (OTCQB:CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent consumer wellness company specializing in... ► Artikel lesen |
17 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| JOHNSON & JOHNSON | 199,78 | -0,23 % | J&J Posts Innovative Medicine Growth in 2025 Amid Stelara Patent Loss | ||
| PROCTER & GAMBLE | 132,32 | +0,26 % | The Procter & Gamble Company (PG): A Bull Case Theory | ||
| LVMH | 529,70 | -0,81 % | LVMH, Hermès & Co: Machtkampf in China - wer bleibt übrig? | China bleibt ein Schlüsselmarkt für LVMH, Hermès & Co. Der Markt kommt wieder in Bewegung, doch die alten Erfolgsrezepte greifen nicht mehr. "China belohnt heute nicht die lautesten Marken, sondern... ► Artikel lesen | |
| STEINHOFF INTERNATIONAL | - | - | People Moves: SCOR Names Swiss Re's Forgeron as P&C Chief Underwriting Officer; Hamilton Re Promotes Steinhoff to CUO | ||
| SONY GROUP | 19,470 | +3,23 % | Stärkeres Weihnachtsgeschäft überrascht den Markt: Sony hebt Prognose erneut an, Aktie reagiert dennoch verhalten | Sony hat nach einem unerwartet starken Weihnachtsquartal seine Gewinnaussichten erneut nach oben angepasst. Trotz der verbesserten Perspektiven zeigte sich die Aktie im Handel kaum verändert und blieb... ► Artikel lesen | |
| LOREAL | 390,75 | +0,58 % | UBS stuft LOREAL auf 'Buy' | ZÜRICH (dpa-AFX Analyser) - Die Schweizer Großbank UBS hat die Einstufung für L'Oreal mit einem Kursziel von 430 Euro auf "Buy" belassen. Die Zahlen des Kosmetikherstellers e.l.f. Beauty ließen positive... ► Artikel lesen | |
| COLGATE-PALMOLIVE | 78,99 | -0,05 % | Aktien New York: Trumps Fed-Nominierung bringt Verluste mit sich | NEW YORK (dpa-AFX) - Die Wahl von US-Präsident Donald Trump für den künftigen Notenbankchef belastet am Freitag die New Yorker Börsen. Weil der vorgeschlagene Nachfolger Kevin Warsh nicht als Verfechter... ► Artikel lesen | |
| RECKITT BENCKISER | 72,04 | -0,58 % | Dividendenbekanntmachungen (02.02.2026) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) ACUITY INC US00508Y1029 0,2 USD 0,1687 EUR ALLY FINANCIAL INC US02005N1000 0,3 USD 0,2531 EUR AMERISERV FINANCIAL INC US03074A1025 0... ► Artikel lesen | |
| RATIONAL | 768,00 | -0,32 % | BERNSTEIN RESEARCH stuft RATIONAL AG auf 'Outperform' | NEW YORK (dpa-AFX Analyser) - Das US-Analysehaus Bernstein Research hat das Kursziel für Rational von 1050 auf 1070 Euro angehoben und die Einstufung auf "Outperform" belassen. Analyst Philippe Lorrain... ► Artikel lesen | |
| PANASONIC | 13,420 | +0,34 % | Panasonic Corp. Nine Months Income Drops | TOKYO (dpa-AFX) - Panasonic Corp. (PCRFF.PK) announced a profit for nine months that Dropped, from the same period last yearThe company's bottom line came in at JPY125.297 billion, or JPY53.66... ► Artikel lesen | |
| SHARKNINJA | 119,57 | 0,00 % | SharkNinja, Inc. (SN): A Bull Case Theory | ||
| TONIES | 11,840 | +1,02 % | tonies erreicht 2025 oberes Ende der Prognose | Die tonies SE hat im Geschäftsjahr 2025 nach vorläufigen Zahlen den Umsatz um 31 Prozent auf 630 Millionen Euro gesteigert, nach 481 Millionen Euro im Vorjahr. Die bereinigte EBITDA-Marge erhöhte sich... ► Artikel lesen | |
| PLAYBOY | 2,110 | 0,00 % | Playboy, Inc.: Playboy Signs $122 Million Deal with United Trademark Group to Accelerate the Growth of its China Business | Playboy to Sell 50% of its China Business, and Receive $112 Million in Guaranteed Payments Playboy to Receive $10 Million for Brand Support Services Major Transaction Advances Asset-Light Strategy... ► Artikel lesen | |
| HAYWARD HOLDINGS | 16,615 | 0,00 % | Here's Why Hayward Holdings Inc. (HAYW) Looks Undervalued After the Recent Selloff | ||
| HERMES INTERNATIONAL | 2.107,00 | +1,74 % | Jim Cramer Says Its 'Just Crazy' That Costco Sells Discounted Hermès Birkin In Chinese Warehouses: 'Love This Stock But...' |
CV SCIENCES INC gehört der Branche Konsumgüter an.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu CV SCIENCES INC finden Sie auf Wallstreet Online.